Adcock Ingram

Adcock Ingram
Formerly	EJ Adcock Pharmacy (at founding)
Company type	Public
Traded as	JSE: AIP
Industry	Health Care, Pharmaceuticals
Founded	1890; 134 years ago
Headquarters	Midrand, South Africa
Area served	South Africa and selected emerging markets.
Key people	Andy Hall, CEO; Dorette Neethling, CFO; Nompumelelo Madisa, Chairman;
Products	Pharmaceuticals and Health Care
Brands	see sections Pharmaceutical brands and Health care brands
Revenue	R7.77 Billion (2021)
Operating income	R947M (2021)
Net income	R511M (2021)
Number of employees	2223 (2021)
Parent	Bidvest Group
Website	www.adcock.com

Adcock Ingram is a South African pharmaceutical manufacturer listed on the Johannesburg Stock Exchange. Adcock Ingram manufactures and markets healthcare products to both the private and public sectors.

^ ^a ^b ^c "Group Annual Financial Statement 2021" (PDF). Adcock Ingram. Retrieved 1 September 2021.^{[self-published source]}
^ "Bidvest now in control of Adcock Ingram as stake increases to 50%". 7 August 2021.

[annualreport2021-1] "Group Annual Financial Statement 2021" (PDF). Adcock Ingram. Retrieved 1 September 2021.^{[self-published source]}

[iol-2] "Bidvest now in control of Adcock Ingram as stake increases to 50%". 7 August 2021.

[1]

[2]